Association between risk factors of metabolic syndrome with lung function

Md Sajid Ahmed; Amtul Rahman Amberina; Abdullah Rehman; Umrana Mirza

doi:10.53730/ijhs.v6nS4.5691

Authors

Md Sajid Ahmed Associate Professor, Department of Pathology, Ayaan Institute of Medical Sciences, Hyderabad
Amtul Rahman Amberina Assistant Professor, Department of Biochemistry, Mahavir Institute of Medical Sciences, Vikarabad, Telangana
Abdullah Rehman Associate Professor, Department of Pathology, Dr. V.R.K. Women's Medical College, Teaching Hospital & Research Centre, Hyderabad
Umrana Mirza Assistant Professor, Department of Biochemistry, Shadan Institute of Medical Sciences, Hyderabad

Keywords:

metabolic syndrome, forced expiratory volume, forced vital capacity

Abstract

Introduction: Increased evidence suggests that metabolic syndrome (MetS) is correlated with lung function impairment. This study aimed to explore the associations between MetS risk factors and the lung function. Material and Method: This is a prospective, observational, descriptive study conducted among patients attending at Tertiary care teaching hospital over a period of 1 year. Inclusion criteria: Either gender above the age of 18 years who fulfilled the International Diabetes Federation (IDF) criteria for Metabolic Syndrome to evaluate pulmonary function test (Spirometry) abnormalities. Results: A total of 60 participants (41 males) were included in the study. The characteristics of the eligible subjects stratified by gender and the presence of metabolic syndrome. The BMI, SBP, DBP, waist circumference was statically significant between male and female (all of the parameters, p<0.05). Fasting Blood glucose, Total Cholesterol, Serum triglycerides, CRP, serum uric acid, and serum total bilirubin statically significant between male and female (all of the parameters, p<0.05). Pulmonary function tests, such as FEV1, FEV1 % predicted, FVC, FVC1 % predicted and FEV1/FVC ratio were statically significant among male and female.

Downloads

Download data is not yet available.

References

Naveed B, Weiden MD, Kwon S, Gracely EJ, Comfort AL, Ferrier N, et al. Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. Am J Respir Crit Care Med. 2012; 185:392–9.

Weiden MD, Kwon S, Caraher E, Berger KI, Reibman J, Rom WN, et al. Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV(1) decline. Semin Respir Crit Care Med. 2015; 36:323–33.

Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013; 93:359–404.

Wehrmeister FC, Menezes AM, Muniz LC, Martinez-Mesa J, Domingues MR, Horta BL. Waist circumference and pulmonary function: a systematic review and meta-analysis. Syst Rev. 2012; 1:55.

Kaneko H, Horie J. Breathing movements of the chest and abdominal wall in healthy subjects. Respir Care. 2012; 57:1442–51.

Kohli S, Sniderman AD, Tchernof A, Lear SA. Ethnic-specific differences in abdominal subcutaneous adipose tissue compart-ments. Obesity (Silver Spring). 2010; 18:2177–83.

Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006; 129:853-62.

Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr. 2008; 17(Suppl 1):37–42.

Faber DR, van der Graaf Y, Westerink J, Visseren FL (2010) Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Atherosclerosis 212: 274–280.

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288:2709–16.

Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005; 127:1952–9.

McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: 1. Epidemiol Thorax. 2008; 63:649–54.

Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005; 28:1472–9.

Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004; 47:195–203.

Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58:388-93.

Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127:1952-9.

Stavem K, Aaser E, Sandvik L, Bjornholt JV, Erikssen G, Thaulow E, et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005; 25:618-25.

Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53:1195-200.

Lin WY, Yao CA, Wang HC, Huang KC. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring) 2006; 14:1654-61.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–52.

Paek YJ, Jung KS, Hwang YI, Lee KS, Lee DR, Lee JU. Association between low pulmonary function and metabolic risk fac-tors in Korean adults: the Korean National Health and Nutrition Survey. Metabolism. 2010; 59:1300–6.

Bottai M, Pistelli F, Di Pede F, Carrozzi L, Baldacci S, Matteelli G, et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J 2002; 20:665-73.

Buist AS, McBurnie MA, Vollmer WM. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study (vol 370, pg 741, 2007). Lancet (London, England). 2012 Sep 1; 380(9844):806-.

Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. European Respiratory Journal. 2008 Jan; 31(1):204–12.

Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. American journal of epidemiology. 2004 Jun 15; 159(12):1140–9.

Fimognari FL, Pasqualetti P, Moro L, Franco A, Piccirillo G, Pastorelli R, et al. The association between metabolic syndrome and restrictive ventilator dysfunction in older persons. The journals of gerontology Series A, Biological sciences and medical sciences. 2007 Jul; 62(7):760–5.

Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008 Oct; 134(4):712–8.

Funakoshi Y, Omori H, Mihara S, Marubayashi T, Katoh T. Association between air ow obstruction and the metabolic syndrome or its components in Japanese men. Intern Med (Tokyo Japan). 2010; 49(19):2093–9.

Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006 Dec 14; 444(7121):881–7.

Yamamoto Y, Oya J, Nakagami T, Uchigata Y. Association between lung function and metabolic syndrome independent of insulin in Japanese men and women. Japanese clinical medicine. 2014; 5:1–8.

Kaneko H, Horie J. Breathing movements of the chest and abdominal wall in healthy subjects. Respiratory care. 2012 Sep; 57(9):1442–51. PubMed PMID: 22348414.

Thompson AM, Zhang YH, Tong WJ, Xu T, Chen J, Zhao L, et al. Association of in inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC endocrine disorders. 2011 Oct; 11.

Ameen NM, El Deen Mohamed RS, El Mageed NIA, El Wahab MHA. The metabolic syndrome in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases Tuberculosis. 2016; 65(3):593–6.